Welcome to LookChem.com Sign In|Join Free

CAS

  • or

102573-86-4

Post Buying Request

102573-86-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102573-86-4 Usage

Physical state

Clear, colorless liquid

Odor

Faint

Primary use

Solvent in manufacturing of adhesives, sealants, and coatings

Secondary use

Stabilizer in production of chlorinated solvents

Health risks

Probable human carcinogen

Hazardous exposure

Inhalation, ingestion, or skin absorption

Regulatory efforts

Ongoing to minimize exposure and protect human health and environment

Check Digit Verification of cas no

The CAS Registry Mumber 102573-86-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,5,7 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 102573-86:
(8*1)+(7*0)+(6*2)+(5*5)+(4*7)+(3*3)+(2*8)+(1*6)=104
104 % 10 = 4
So 102573-86-4 is a valid CAS Registry Number.

102573-86-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-ethynyl-2,2-dimethyl-1,3-dioxane

1.2 Other means of identification

Product number -
Other names 5-Ethynyl-2,2-dimethyl-[1,3]dioxane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102573-86-4 SDS

102573-86-4Relevant articles and documents

COMPOUNDS AND USES THEREOF

-

, (2019/11/11)

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

An Approach to Pseudomonic Acids from Acetylenic Precursors: Synthesis of 2-(Hydroxymethyl)-3-butyn-1-ol

Bates, Hans Aaron,Farina, James,Tong, Michael

, p. 2637 - 2641 (2007/10/02)

The acetonide of 2-(hydroxymethyl)-3-butyn-1-ol (17) was prepared from bis(hydroxymethyl)malonate (11) or from 1,3-dihydroxypropanone (22).Alternative routes to 17 involving the intermediacy of highly unstable alkynal 21 or the corresponding acetate were unsuccessful.Condensation of the anion of 17 with aldehyde 30 followed by semihydrogenation and deprotection afforded keto triol 33, which cyclized stereoselectively to dihydropyran 34.Osmylation and functional group manipulation afforded 40 and 42, precursors to pseudomonic acid C (1).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 102573-86-4